Avid Bioservices Inc (CDMO)

[Protector]

Pembro(lizumab) PD-1 & Bavituximab trial halve-way

CDMO has a profit share agreement (15+%) on this and all other Bavituximab related stuff. And there are milestone agreements.

A Study of Pembrolizumab and Bavituximab in Patients With Advanced Hepatocellular Carcinoma (Merck Sharp & Dohme Corp. @UTSW)

This (see TV show movie link embedded) is one of the inventors when at Organon (-->Schering-Plough-->Merck & Co.).
TV Interview (Dutch) + Jimmy Carter's testemony in English about minute 10

Remember that Avid manufactures Bavituximab and that (see last Quarterly statements) companies cannot easily change manufacturer for this class of products. So certainly for clinical trials only it would eat seriously out of Oncology's budget to move that production away from CDMO (if they could).

And this one got attention in MAY 2019
Bavi + radiation